The Rising Influence of Rising Affluence

[semi_infinite]

VCEL - Q4 ER slides. Correction - Epicel grew low double digits on annual basis although Q4 YOY change was flattish. MACI annual growth was 35%. Guidance appears conservative once again notwithstanding uncertain future impact from Covid19 on procedure volume. Number of MACI sales rep to hit 76 in Q2 up from 49 at year end 2019.

http://investors.vcel.com/static-files/02e8a9b8-3239-4b71-8ce9-43a3f7a0990c